Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.

NCT05115942 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Fibrosis

Interventions

DRUG: Hydronidone capsules
DRUG: The placebo capsules

Sponsor

Beijing Continent Pharmaceutical Co, Ltd.